Loading...
XNAS
SNWV
Market cap100mUSD
Jul 10, Last price  
11.68USD
1D
-3.43%
1Q
-30.64%
Jan 2017
6,578.10%
IPO
122.48%
Name

SANUWAVE Health

Chart & Performance

D1W1MN
XNAS:SNWV chart
P/E
8.50
P/S
2.28
EPS
1.37
Div Yield, %
Shrs. gr., 5y
55.21%
Rev. gr., 5y
61.12%
Revenues
44m
+34.98%
000660,725728,446802,572769,217800,029847,367965,5011,376,063738,5271,850,0601,028,7304,057,00013,010,00016,742,00020,398,00032,634,00044,051,000
Net income
12m
P
21,987-35,692-26,550-6,153,040-14,922,441-10,238,797-6,401,494-11,299,721-5,974,080-4,810,285-6,439,040-5,537,936-11,631,394-10,429,839-30,937,000-27,259,000-10,293,000-25,807,000-31,372,00011,813,000
CFO
4m
+57.88%
-4,072-22,072-41,923-6,271,932-5,867,276-8,831,699-4,290,121-3,924,204-6,678,369-3,473,456-3,199,453-1,528,971-3,621,172-6,410,758-12,718,000-6,409,000-17,169,000-4,538,0002,455,0003,876,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
IPO date
Nov 07, 2008
Employees
38
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT